Inhibition of intestinal motility by anandamide, an endogenous cannabinoid

European Journal of Pharmacology

Volumn 340, Issue 2-3, 1997, Pages

  Calignano, A ^a   La Rana, G ^a   Makriyannis, A ^a   Lin, S Y ^a   Beltramo, M ^a   Piomelli, D ^a  

^a Neurosciences Inc   (United States)

Author keywords

Anandamide; Cannabinoid; Intestinal transit

Indexed keywords

ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR ANTAGONIST; CHARCOAL; N (4 HYDROXYPHENYL)ARACHIDONYLETHANOLAMIDE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG TRANSPORT; INTESTINE MOTILITY; MALE; MEMBRANE TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; CELL MEMBRANE; GASTROINTESTINAL MOTILITY; MALE; MICE; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0031565117     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)